Company intelligence / Profile preview

Renaissance Rx

New Orleans, Louisiana, United Statesnytimes.com ↗

Ownership: Private
Development stage: Commercial

Overview

Renaissance Rx specialized in personalized medicine through genetic testing, aiming to help physicians determine optimal medications based on patients' genetic profiles. The company experienced rapid growth after its founding in 2012 but faced financial and legal troubles by the mid-to-late 2010s, including layoffs, lawsuits, and a federal settlement over alleged kickbacks. It is now out of business.

Modalities: Genetic testing (Personalized medicine)
Industry: Molecular Diagnostics

Partnerships

TPG Growth (investor/partner)

Beyond the preview

Go deeper on Renaissance Rx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renaissance Rx.

Explore the full profile